ScholarIQanswers from OpenAlex

Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions

PaperCitations, authors & open-access status

Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions have?

ScholarIQcitation count

Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions published?

ScholarIQyear

Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions has 2025 year in the ScholarIQ index.

What is the open-access status of Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions?

ScholarIQoa status

Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions has bronze oa status in the ScholarIQ index.

What is the DOI of Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions?

ScholarIQdoi

The DOI for Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions is on the source record.

What is the OpenAlex record for Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions?

ScholarIQopenalex

The OpenAlex for Antithrombotic Therapy in Patients With Isolated Peripheral Arterial Disease Undergoing Peripheral Vascular Interventions is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial